Stay updated on Mepolizumab in Severe Asthma: Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab in Severe Asthma: Clinical Trial page.

Latest updates to the Mepolizumab in Severe Asthma: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange Detected- Added Revision: v3.4.3; removed Revision: v3.4.2.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision label updated: added v3.4.2 and removed v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check38 days agoChange DetectedMinor revision update from v3.4.0 to v3.4.1 with no visible changes to the page content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check53 days agoChange DetectedGlossary toggle controls (Show glossary / Hide glossary) were added to aid understanding, and the footer/labels were updated to show 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check61 days agoChange DetectedRevision updated to v3.3.4, replacing the previous v3.3.3.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded a comprehensive Locations section listing multiple Chinese regions (Fujian, Guangdong, Guizhou, Hebei, Henan, Hubei, Hunan, Inner Mongolia, Jiangsu, Jilin, Liaoning, Ningxia, Shandong, Shanxi, Sichuan, Xinjiang, Zhejiang) and the Revision: v3.3.3; removed individual per-location entries to reorganize the site listings.SummaryDifference1%

Stay in the know with updates to Mepolizumab in Severe Asthma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab in Severe Asthma: Clinical Trial page.